Get the most recent information about coronavirus (COVID-19) from Tufts Health Freedom Plan or for more information visit the CDC website. We're with you.
On January 6 and 7, 2020, Denton Pharma, Inc. dba Northwind Pharmaceuticals, and Appco Pharma LLC, manufacturers of ranitidine, issued a voluntary recall of ranitidine capsules and tablets. This recall was issued because an unexpected impurity was found in these products that may cause health risks.
For more information or to report any adverse events or quality problems experienced with the use of this product, contact Denton Pharma, Inc. dba Northwind Pharmaceuticals, Appco Pharma LLC or the FDA's MedWatch Program.
Manufacturers
To report an adverse event to the FDA Med Watch Program:
Denton Pharma, Inc. dba Northwind Pharmaceuticals
Appco Pharma LLC